HTP high-yield IVT protein expression

Subjects:


Featured Products:

1-Step Human High-Yield IVT Kits

1-Step Human High-Yield IVT Kits

Pierce 96-well Microdialysis Plates

Pierce 96-well Microdialysis Plates


Related Products:


Author Affiliations:

Thermo Fisher Scientific, Rockford, IL

Contact:

Atul Deshpande

Managing Editor:

Douglas Hayworth


Trademark symbols (™) and asterisks (*) denote trademark names, usually of other companies (see link in website footer). Thermo Scientific, Pierce and most other product names are trademarks of Thermo Fisher Scientific.

© Thermo Fisher Scientific Inc.

 

System for high-throughput, high-yield in vitro translation

HTP protein expression using 1-Step Human High-Yield IVT Kits and Pierce 96-well Microdialysis Plates.

Greg Kilmer, B.S.; Brian Webb, Ph.D.; Atul Deshpande, Ph.D.; Krishna Vattem, Ph.D.;

January 10, 2014


Cell-free, in vitro translation (IVT) systems enable small amounts of proteins to be produced quickly. Protein expression protocols that can be adapted to high-throughput (HTP) techniques provide an efficient means for producing a large number of recombinant proteins for use in screening and other research applications. Here we demonstrate the speedy and efficient simultaneous expression of several proteins using the Thermo Scientific 1-Step Human High-Yield IVT System applied to 96-well microdialysis plates.

The Mini IVT Kit (Part No. 88892) contains separate microdialysis devices to perform individual 100µL reactions, where each device is incubated in a separate 2mL microcentrifuge tube. Thermo Scientific Pierce 96-well Microdialysis Plates (Part No. 88260) contain 8-segment strips of these same microdialysis devices (Figures 1 and 2), enabling protein expression in an automation-compatible, 96-well format.

Figure 1. The Pierce 96-well Microdialysis Plate.

Figure 1. The Pierce 96-well Microdialysis Plate. Each plate is pre-loaded with twelve 8-segment cartridges. The assembled device is compatible with standard 96-well laboratory equipment and automated liquid-handling systems, making it an ideal option for high-throughput applications. Single microdialysis devices can be used independently in 2mL microcentrifuge tube for processing single samples. Available plate seals are made of high-quality polypropylene and help protect samples from contamination and evaporation during incubation periods.

 

Figure 2. Dialysis protocol summary for the Pierce 96-well Microdialysis Plate.

Figure 2. Dialysis protocol summary for the Pierce 96-well Microdialysis Plate. For IVT reactions, the devices are used in the same manner as they are for dialysis, except that the sample and dialysis buffer are replaced with the template-containing reaction mixture and the kit-specific dialysis buffer, respectively.


RESULTS and DISCUSSION:

We validated the 96-well HTP format by performing replicate IVT reactions in eight wells of a microdialysis plate (two 4-segment cartridges). We expressed TurboGFP (green fluorescent protein) using the positive control DNA (pCFE-GFP) that is supplied in the IVT kits. Our protocol was identical to the kit procedure (Part No. 88891) for four 100µL reactions. We incubated the reactions for 18 hours at 30°C.

Expression was favorable and consistent in all eight test wells, producing in an average of 461µg/mL GFP per well (Figure 3). Even before removing sample for quantitation in an assay plate, GFP expression is visually evident in the microdialysis devices (Figure 4). These values are comparable to results obtained with the default IVT kit procedure, in which the devices are incubated in 2mL microcentrifuge tubes (data not shown).

Figure 3. Consistent, high-yield expression of GFP in a high-throughput IVT format.

Figure 3. Consistent, high-yield expression of GFP in a high-throughput IVT format. As part of a larger experiment, GFP was expressed in 8 different wells of a 96-well microdialysis plate (separate 4-segmented cartridge in rows 1 and 11). For this assay, aliquots of each reaction were tested in a black 384-well plate against serial dilutions of a standard, Recombinant GFP (Part No. 88899), using a fluorescence plate reader.

 

Figure 4. Visual inspection of GFP expression.

Figure 4. Visual inspection of GFP expression. Visible (left) and fluorescent (right, FITC-filter) images of GFP expressed in four adjoining wells (dialysis segments) of a 96-well microdialysis plate.


CONCLUSIONS:

We have successfully demonstrated the use of Pierce 96-well Microdialysis Plates for high-throughput expression of proteins with the 1-Step High-Yield Mini IVT Kits. We conclude that switching from microcentrifuge tubes to the microdialysis plate for IVT reactions in the microdialysis devices facilitates rapid and consistent expression of up to 96 proteins at a time.


METHODS:

In vitro Translation (IVT)

The protocol was identical to the default procedure for the 1-Step Human High-Yield Mini IVT Kit (Part No. 88891) for four 100µL reactions, except that the microdialysis devices containing the reactions were incubated in a Pierce 96-well Microdialysis Plate (Part No. 88260) instead of 2mL microcentrifuge tubes. Reactions were incubated for 18 hours at 30°C.

Measurement of GFP Expression

For quick visual detection, the microdialysis devices containing the GFP reactions were viewed using a Molecular Imager VersaDoc™ MP 4000 System (Bio-Rad Laboratories, Inc.) with a FITC filter (ex/em: 482/512nm), 0.1 sec exposure, aperture 4.

Quantitation using fluorescent plate reader: 10µL aliquots of each reaction were diluted 15-fold with phosphate-buffered saline (PBS) containing 0.1% BSA to yield 150µL test samples. A set of standards was prepared from recombinant tGFP protein of known concentration (Part No. 88899) by serial dilution (50µg/mL to 0.78µg/mL) in 0.1% BSA-PBS. Triplicates of test samples and standards (25µL) were pipetted into wells of a black 384-well plate and the fluorescence values measured by a Tecan™ Safire™ Fluorescent Plate Reader at ex/em: 482/512nm. Concentrations of test samples were calculated by reference to the standard curve.

Additional methods for detecting and measuring expression of GFP from the control DNA (pCFE-GFP) supplied in the IVT Kits are described in the product instructions. Be aware that the tGFP control protein is from the copepod Pontellina plumata. This GFP is not reactive to antibodies generated against Aequorea victoria GFP (i.e., EGFP or other EGFP mutants). Instead, use polyclonal antibodies to TurboGFP (Ab. No. PA5-22688) for Western blot detection.


GENERAL REFERENCES:

  1. Kobayashi, T., et al. (2013). Purification and visualization of encephalomyocarditisvirus synthesized by an in vitro protein expression system derived from mammalian cell extract. Biotechnol. Lett. 35: 309-14.
  2. Masutani, M., et al. (2012). Reconstitution of eukaryotic translation initiation factor 3 by co-expression of the subunits in a human cell-derived in vitro protein synthesis system. Protein Expr Purif. 87: 5-10.
  3. Yanagiya, A., et al. (2012). Translational homeostasis via the mRNA cap-binding protein, eIF4E. Mol. Cell. 46: 847-58. Epub 2012 May 10.